Jane Street Group, LLC Coherus Bio Sciences, Inc. Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	BUY	$15.81 - $18.99 $71,145 - $85,455	4,500 Added 35.43%	17,200 $275,000
Q3 2021 Nov 16, 2021	SELL	$12.68 - $17.79 $116,656 - $163,668	-9,200 Reduced 42.01%	12,700 $204,000
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $124,320 - $147,936	9,600 Added 78.05%	21,900 $303,000
Q2 2020 Aug 17, 2020	BUY	$14.43 - $19.16 $177,489 - $235,668	12,300 New	12,300 $220,000

135

78M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $108M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.